Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marco Del Carria
Institutions:
Azienda Ospedaliero-Universitaria Careggi,
University of Florence
Observed institutions:
Azienda Ospedaliero-Universitaria Careggi,
University of Florence
ORCID:
0009-0007-0955-2417
Observed ORCID:
0009-0007-0955-2417
OpenAlex ID:
A5074774639
Urinary rituximab loss and rate of treatment failure in membranous nephropathy
2025
·
Marco Allinovi
, Matteo Accinno
, et al.
·
Nephrology Dialysis Transplantation
·
24
Anti-protein arginine deiminase antibodies are distinctly associated with joint and lung involvement in rheumatoid arthritis
2022
·
Boaz Palterer
, Gianfranco Vitiello
, et al.
·
Rheumatology
·
18
PDF
Presentation and progression of MPO-ANCA interstitial lung disease
2024
·
Lorenzo Salvati
, Boaz Palterer
, et al.
·
Journal of Translational Autoimmunity
·
13
Late initiation of anakinra can induce complete renal response in renal AA amyloidosis secondary to Familial Mediterranean Fever
2024
·
Marco Allinovi
, Lorenzo Salvati
, et al.
·
Journal of Nephrology
·
2
PDF
Atypical posterior reversible encephalopathy syndrome (PRES) as onset of giant cell arteritis (GCA)
2023
·
Marco Del Carria
, Massimo Del Panta
, et al.
·
Rheumatology
·
1
PDF
Subacute Cutaneous Lupus Erythematosus Following COVID-19 Vaccination: A Case Report after BNT162b2 Vaccine and Literature Review
2026
·
Lorenzo Salvati
, Marco Del Carria
, et al.
·
ASIDE Case Reports
PDF
Eosinophilic hepatitis successfully treated with mepolizumab
2025
·
Antonino Marcello Pilia
, Lorenzo Salvati
, et al.
·
Frontline Gastroenterology
Show more works
View as search
Works count:
7
Citation count:
58
H-index:
3
I10-index:
3
Year
Topic
Type